Hill Holliday managing director and 17-year agency veteran Scott Rabschnuk will lead the practice alongside David Leonardi, who joined the agency as an executive creative director in 2013 and has worked on brands including Lipitor, Prevacid, Lap-Band and Spiriva.
“There are intangible qualities and commitment with everyone here; our collective passion for helping people is real,” Leonardi (pictured, left) said in a statement. “We use every ounce of that to create work that breaks through and helps change—or even save—lives.”
“Over the past decade, our healthcare expertise has grown quietly yet tremendously, driving results for some of the biggest names in the industry,” added Hill Holliday chairman and CEO Karen Kaplan. “Now is the time to raise the profile of this growth engine to attract healthcare clients and agency talent more effectively.”
Hill Holliday Health encompasses 150 employees across its Boston and New York offices. The practice acts as agency of record for Xarelto and Invokana and also serves clients including Novartis, Alcon, Johnson & Johnson’s Janssen division, Optum, Harvard Pilgrim Health Care and ALK.
Hill Holliday first launched its healthcare practice in 2007, with CVS, Partners HealthCare, EmblemHealth, and Harvard Pilgrim Health Care as launch clients.